ELVN
USDEnliven Therapeutics Inc. Common Stock
$17.630-0.540 (-2.972%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$18.170
High
$18.310
Low
$16.800
Volume
0.26M
Company Fundamentals
Market Cap
1.0B
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.53M
Exchange
NMS
Currency
USD
52-Week Range
Low $13.3Current $17.630High $29.38
Related News
PR Newswire
Enliven Therapeutics Announces Clinical Data in CML Patients with Atypical Fusion Transcripts at ASH 2025 Annual Meeting
Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and...
View more
Related Stocks
IGTAW
Inception Growth Acquisition Limited Warrants
NASDAQ
Blank Checks
WSBCP
WesBanco Inc. Depositary Shares Each Representing a 1/40th Interest in a Share of 6.75% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock Series A
NASDAQ
Major Banks
OPINL
Office Properties Income Trust 6.375% Senior Notes due 2050
NASDAQ
Real Estate
AVT
Avnet Inc.
NASDAQ
Electronic Comp...
PRKS
United Parks & Resorts Inc.
NASDAQ
Biotechnology: ...
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.